Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Mediators of Inflammation|March 14, 2014
Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantationIrene García Cadenas, David Valcarcel, Rodrigo Martino, et al.Clinical Lymphoma, Myeloma & Leukemia|May 24, 2022
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue PlasmacytomasDavid F Moreno, Victoria Clapés, Juan Alfons Soler, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2012
Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host diseaseIrene García-Cadenas, David Valcárcel, Rodrigo Martino, et al.Transplantation and Cellular Therapy|November 10, 2021
Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and ChallengesSara Redondo, Albert Esquirol, Silvana Novelli, et al.Haematologica|December 7, 2007
Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcomeCarme Talarn, Alvaro Urbano-Ispizua, Rodrigo Martino, et al.Mycopathologia|June 22, 2020
Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002-2018 Empirical/Pre-emptive ApproachRodrigo Martino, Ana Garrido, Marta Santaliestra, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2006
Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignanciesFrancesc Fernández-Avilés, Enric Carreras, Alvaro Urbano-Ispizua, et al.Haematologica|October 5, 2006
Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantationMiquel Granell, Alvaro Urbano-Ispizua, Juan Ignacio Aróstegui, et al.Clinical Lymphoma, Myeloma & Leukemia|July 19, 2018
Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to TherapyEva Puy Vicente, Carolina Cuellar-García, Montserrat Martinez, et al.Transplantation and Cellular Therapy|February 8, 2022
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance TreatmentMarta Reinoso-Segura, Teresa Caballero-Velázquez, Pilar Herrera, et al.Pageof 4